PJ Burke - Concepedia

Concepedia

Author

PJ Burke

Johns Hopkins Medicine

Also Known As

PJ Burke

29

Publications

974

Citations

15

H-Index

18

Concepts

All Affiliations

Johns Hopkins Medicine Johns Hopkins University Charing Cross Hospital Johns Hopkins Hospital

PB

About

PJ Burke is an author at Johns Hopkins Medicine specializing in medicine, biochemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	180
2	Biochemistry	4	4	152
3	Natural Sciences	1	1	75
4	Biomolecular Engineering	1	1	15
5	Cell Biology	1	1	75

PJ Burke

×

17

Publications

941

Citations

15

H-Index

	Year	Citations
Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia E Schneider, KH Cowan, Hasan Bader, Blood	1995	175
Two-cycle timed-sequential chemotherapy for adult acute nonlymphocytic leukemia Vaughan Wp, JE Karp, PJ Burke Blood	1984	123
Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia JE Karp, R. G. Wyn Jones, CB Miller, Blood	1994	111
Immunoglobulin gene rearrangements in remission bone marrow specimens from patients with acute lymphoblastic leukemia BA Zehnbauer, DM Pardoll, PJ Burke, Blood	1986	79
A two-step timed sequential treatment for acute myelocytic leukemia RB Geller, PJ Burke, JE Karp, Blood	1989	78
Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model SK Sharma, K D Bagshawe, PJ Burke, British Journal of Cancer Signal TransductionBiochemistryNatural SciencesProtein EngineeringMedicine	1990	75
A rationale for sequential high-dose chemotherapy of leukemia timed to coincide with induced tumor proliferation PJ Burke, W P Vaughan, JE Karp Blood	1980	49
Disposition of the prodrug 4-(bis (2-chloroethyl) amino) benzoyl-L-glutamic acid and its active parent drug in mice Pari Antoniw, Springer Cj, K D Bagshawe, British Journal of Cancer Pharmaceutical SciencePharmacological StudyBiochemistryActive Parent DrugMedicine	1990	41
In vivo cell growth and pharmacologic determinants of clinical response in acute myelogenous leukemia JE Karp, Donehower Rc, JP Enterline, Blood	1989	40
Timed sequential chemotherapy of cytoxan-refractory multiple myeloma with cytoxan and adriamycin based on induced tumor proliferation JE Karp, RL Humphrey, PJ Burke Blood	1981	28

Page 1